Literature DB >> 2457390

Location of sites in human lipocortin I that are phosphorylated by protein tyrosine kinases and protein kinases A and C.

L Varticovski1, S B Chahwala, M Whitman, L Cantley, D Schindler, E P Chow, L K Sinclair, R B Pepinsky.   

Abstract

Lipocortin I is a 39-kilodalton membrane-associated protein that in A431 cells is phosphorylated on tyrosine in response to epidermal growth factor (EGF). We have used recombinant human lipocortin I as a substrate for several protein kinases and identified phosphorylated residues by a combination of peptide mapping and sequence analysis. Lipocortin I was phosphorylated near the amino terminus at Tyr-21 by recombinant pp60c-src. The same tyrosine residue was phosphorylated by polyoma middle T/pp60c-src complex, by recombinant pp50v-abl, and with A431 cell membranes by the EGF receptor/kinase. The primary site of phosphorylation by protein kinase C was also near the amino terminus at Ser-27. The major site of phosphorylation by adenosine cyclic 3',5'-phosphate dependent protein kinase was on the carboxy-terminal half of the molecule at Thr-216. These sites are compared to the phosphorylation sites previously located in the structurally related protein lipocortin II.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2457390     DOI: 10.1021/bi00410a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Integrated Microfluidics for Protein Modification Discovery.

Authors:  Meirav Noach-Hirsh; Hadas Nevenzal; Yair Glick; Evelin Chorni; Dorit Avrahami; Efrat Barbiro-Michaely; Doron Gerber; Amit Tzur
Journal:  Mol Cell Proteomics       Date:  2015-08-14       Impact factor: 5.911

2.  Quantitative phosphoproteomic analysis of the tumor necrosis factor pathway.

Authors:  Greg T Cantin; John D Venable; Daniel Cociorva; John R Yates
Journal:  J Proteome Res       Date:  2006-01       Impact factor: 4.466

Review 3.  Annexins: calcium-binding proteins of multi-functional importance?

Authors:  J Römisch; E P Pâques
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

4.  A dimeric form of lipocortin-1 in human placenta.

Authors:  R B Pepinsky; L K Sinclair; E P Chow; B O'Brine-Greco
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

5.  Activated protein kinase C alpha associates with annexin VI from skeletal muscle.

Authors:  C Schmitz-Peiffer; C L Browne; J H Walker; T J Biden
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

6.  Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.

Authors:  Ming-Jen Sheu; Chien-Feng Li; Ching-Yih Lin; Sung-Wei Lee; Li-Ching Lin; Tzu-Ju Chen; Li-Jung Ma
Journal:  Tumour Biol       Date:  2014-05-09

7.  Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells.

Authors:  P Raynal; F Hullin; J M Ragab-Thomas; J Fauvel; H Chap
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

8.  Regulation of annexin I-dependent aggregation of phospholipid vesicles by protein kinase C.

Authors:  S A Johnstone; I Hubaishy; D M Waisman
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

9.  Protein-synthesis-dependent induction of annexin I by glucocorticoid.

Authors:  W T Wong; S C Frost; H S Nick
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

10.  Translocation of lipocortin (annexin) 1 to the membrane of U937 cells induced by phorbol ester, but not by dexamethasone.

Authors:  S A Kang; Y J Cho; H B Moon; D S Na
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.